Biopsy Needle Market Analysis

Product (Biopsy Needle Guns, Biopsy Needles)

Biopsy needle guns segment is poised to hold over 64.1 % biopsy needle market share by the end of 2037. Biopsy needle guns are crucial in treating patients in procedures requiring rapid, accurate, and efficient results. The features associated with biopsy guns that make the procedure more effortless are their adjustable needle depth, handheld designs, and availability in various sizes. Biopsy needle guns offer enhanced accuracy, and reduce risks and complications, with valuable outcomes for healthcare professionals, and practitioners. The demand for biopsy guns has improved efficiency in healthcare settings and has led the field toward a revolutionized and advanced approach to diagnostics.

Application (Cancer, Autoimmune Disorder, Infectious Diseases)

The cancer segment is expected to register a staggering CAGR throughout the forecast period. Breast cancer and prostate cancer are the most highlighted sub-segments of cancer applications. The diverse range of emerging cancer cases has increased the demand for biopsy needles making it a significant diagnostics tool. In July 2021, GE Healthcare installed Serena Bright, the first-contrast-guided biopsy solution in 5 leading hospitals in the U.S. to support clinicians and patients in their fight against breast cancer.

Our in-depth analysis of the biopsy needle market includes the following segments: